{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:19:35Z","timestamp":1793899175337,"version":"4.8.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":227,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:42:45Z","timestamp":1724424165000},"page":"1054-1068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disease Burden and Spectrum of Symptoms That Impact Quality of Life in Pediatric Patients With Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7177-2791","authenticated-orcid":false,"given":"Mirna","family":"Chehade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S.","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Zevit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Pela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Khodzhayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juby","family":"Jacob-Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2024.08.009_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.14309\/ajg.0000000000001777","article-title":"Disease burden and unmet need in eosinophilic esophagitis","volume":"117","author":"Bredenoord","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaip.2018.05.038","article-title":"Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research","volume":"6","author":"Chehade","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastha.2024.08.009_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MPG.0b013e3181788282","article-title":"14 years of eosinophilic esophagitis: clinical features and prognosis","volume":"48","author":"Spergel","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820980860","article-title":"Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults","volume":"14","author":"Visaggi","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.15231","article-title":"Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"49","author":"Navarro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2024.08.009_bib7","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cgh.2021.10.028","article-title":"A\u00a0gap in care leads to progression of fibrosis in eosinophilic esophagitis patients","volume":"20","author":"Chang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MCG.0000000000000297","article-title":"Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter","volume":"50","author":"Lipka","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A\u00a0phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastha.2024.08.009_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000477391","article-title":"Progression from an inflammatory to a fibrostenotic phenotype in eosinophilic esophagitis","volume":"11","author":"Koutlas","year":"2017","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001741","article-title":"Nutritional state and feeding behaviors of children with eosinophilic esophagitis and gastroesophageal reflux disease","volume":"66","author":"Mehta","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1399-3038.2012.01340.x","article-title":"Behavioral feeding problems and parenting stress in eosinophilic gastrointestinal disorders in children","volume":"23","author":"Wu","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.iac.2008.09.014","article-title":"Clinical presentation of feeding dysfunction in children with eosinophilic gastrointestinal disease","volume":"29","author":"Haas","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.gastha.2024.08.009_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.anai.2019.03.020","article-title":"Feeding difficulties in children with non-IgE-mediated food allergic gastrointestinal disorders","volume":"122","author":"Chehade","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPG.0b013e31829ce5ad","article-title":"Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis","volume":"57","author":"Harris","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jpepsy\/jsaa095","article-title":"Treatment burden for pediatric eosinophilic esophagitis: a cross-sectional survey of carers","volume":"46","author":"Hannan","year":"2021","journal-title":"J\u00a0Pediatr Psychol"},{"key":"10.1016\/j.gastha.2024.08.009_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MPG.0000000000000451","article-title":"Health-related quality of life over time in children with eosinophilic esophagitis and their families","volume":"59","author":"Klinnert","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib20","first-page":"85","article-title":"Elimination diets in the management of eosinophilic esophagitis","volume":"7","author":"Wechsler","year":"2014","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.gastha.2024.08.009_bib21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/ajg.2017.202","article-title":"Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept","volume":"112","author":"Greuter","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jaip.2018.06.012","article-title":"Eosinophilic esophagitis and the eosinophilic gastrointestinal diseases: approach to diagnosis and management","volume":"6","author":"Steinbach","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastha.2024.08.009_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","article-title":"Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick","volume":"130","author":"Aceves","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaip.2015.06.024","article-title":"Longitudinal perspective on managing refractory eosinophilic esophagitis","volume":"3","author":"Leung","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastha.2024.08.009_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gastha.2024.08.009_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmed.2018.00247","article-title":"Eosinophilic esophagitis: review and update","volume":"5","author":"Gomez Torrijos","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gastha.2024.08.009_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gtc.2014.02.012","article-title":"Eosinophilic esophagitis: clinical presentation in children","volume":"43","author":"Liacouras","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.gastha.2024.08.009_bib35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13052-021-01178-2","article-title":"Pediatric eosinophilic esophagitis: a review for the clinician","volume":"47","author":"Barni","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPG.0000000000003530","article-title":"Characterization of eosinophilic esophagitis from the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN","volume":"75","author":"Oliva","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy015","article-title":"Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course","volume":"31","author":"Shaheen","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.gastha.2024.08.009_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/CEG.S175061","article-title":"Eosinophilic esophagitis: early diagnosis is the key","volume":"12","author":"Muir","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13052-023-01410-1","article-title":"Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features","volume":"49","author":"Votto","year":"2023","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.dld.2020.11.025","article-title":"Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis","volume":"53","author":"Hoofien","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastha.2024.08.009_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/MOP.0000000000000698","article-title":"Pediatric eosinophilic esophagitis: updates for the primary care setting","volume":"30","author":"Ruffner","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib43","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/ajg.2017.131","article-title":"Influence of age and eosinophilic esophagitis on esophageal distensibility in a pediatric cohort","volume":"112","author":"Menard-Katcher","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib44","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1398-9995.2012.02881.x","article-title":"Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort","volume":"67","author":"Lieberman","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.gastha.2024.08.009_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2021.03.047","article-title":"Medication adherence aligns with age and a behavioral checklist but not symptoms or quality of life for patients with eosinophilic esophagitis","volume":"235","author":"Mehta","year":"2021","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.23736\/S0026-4946.20.05913-7","article-title":"Behavioral issues and quality of life in children with eosinophilic esophagitis","volume":"72","author":"Votto","year":"2020","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jpepsy\/jsx117","article-title":"Evidence of disturbed sleep in children with eosinophilic esophagitis and persistent epigastric pain","volume":"43","author":"Lynch","year":"2018","journal-title":"J\u00a0Pediatr Psychol"},{"key":"10.1016\/j.gastha.2024.08.009_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2015.09.015","article-title":"High rate of failure to thrive in a pediatric cohort with eosinophilic esophagitis","volume":"116","author":"Paquet","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.aller.2019.07.013","article-title":"Children with eosinophilic esophagitis in real life: 10 years' experience with a focus on allergic management","volume":"48","author":"Azzano","year":"2020","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.gastha.2024.08.009_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MPG.0000000000002215","article-title":"Pediatric eosinophilic esophagitis: results of the European Retrospective Pediatric Eosinophilic Esophagitis Registry (RetroPEER)","volume":"68","author":"Hoofien","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.iac.2008.09.011","article-title":"Psychological impact of eosinophilic esophagitis on children and families","volume":"29","author":"Klinnert","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.gastha.2024.08.009_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ajg.2014.316","article-title":"Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States","volume":"110","author":"Jensen","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib53","first-page":"S1","article-title":"Cost comparison of steroids vs different elimination diet for the treatment of eosinophilic esophagitis in children","volume":"63","author":"Schwartz","year":"2016","journal-title":"JPGN"},{"key":"10.1016\/j.gastha.2024.08.009_bib54","first-page":"643","article-title":"Hospitalization trends and determinants of inpatient costs for eosinophilic esophagitis patients in the United States: results from the Nationwide Inpatient Sample analysis","volume":"34","author":"Eke","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.anai.2019.04.010","article-title":"Cost-effective care in eosinophilic esophagitis","volume":"123","author":"Dellon","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib56","first-page":"12","article-title":"Cost of chronic inflammatory disease: the impact of eosinophilic esophagitis in Nevada","volume":"21","author":"Anderson","year":"2020","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.gastha.2024.08.009_bib57","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.14309\/01.ajg.0000774032.05163.28","article-title":"S390. Estimating the indirect and intangible costs associated with eosinophilic\u00a0esophagitis","volume":"116","author":"Fan","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1377\/hlthaff.2018.05144","article-title":"It's still the prices, stupid: why the US spends so much on health care, and a tribute to Uwe Reinhardt","volume":"38","author":"Anderson","year":"2019","journal-title":"Health Aff"},{"key":"10.1016\/j.gastha.2024.08.009_bib59","author":"Gunja"},{"key":"10.1016\/j.gastha.2024.08.009_bib60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/MPG.0000000000003303","article-title":"Transition of care from pediatric to adult care in eosinophilic esophagitis: insights from a patient perspective survey","volume":"73","author":"Robinson","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1442-2050.2011.01315.x","article-title":"Health-care transition from pediatric to adult-focused gastroenterology in patients with eosinophilic esophagitis","volume":"26","author":"Dellon","year":"2013","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.gastha.2024.08.009_bib62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MPG.0000000000001415","article-title":"Lack of knowledge and low readiness for health care transition in eosinophilic esophagitis and eosinophilic gastroenteritis","volume":"65","author":"Eluri","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib63","first-page":"13","article-title":"Transition of care of patients with eosinophilic gastrointestinal diseases: challenges and opportunities","volume":"6","author":"Hiremath","year":"2022","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/j.gastha.2024.08.009_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MPG.0b013e3181b66dbd","article-title":"Severe dysphagia in children with eosinophilic esophagitis and esophageal stricture: an indication for balloon dilation?","volume":"50","author":"Robles-Medranda","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MPG.0000000000001247","article-title":"Savary dilation is safe and effective treatment for esophageal narrowing related to pediatric eosinophilic esophagitis","volume":"63","author":"Al-Hussaini","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/1744666X.2020.1801419","article-title":"Elimination diets for eosinophilic esophagitis: making the best choice","volume":"16","author":"Chehade","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib67","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib68","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.2003.07390.x","article-title":"Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents","volume":"98","author":"Markowitz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaip.2016.12.026","article-title":"Dietary therapy and nutrition management of eosinophilic esophagitis: a work group report of the American Academy of Allergy, Asthma, and Immunology","volume":"5","author":"Groetch","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastha.2024.08.009_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.713027","article-title":"Endoscopy in pediatric eosinophilic esophagitis","volume":"9","author":"Nguyen","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib71","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.jaip.2023.04.047","article-title":"When supplemental formula is essential: overcoming barriers to hypoallergenic formula access for patients with food allergies","volume":"11","author":"Schultz","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.gastha.2024.08.009_bib72","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00455-016-9739-1","article-title":"The six-food elimination diet for eosinophilic esophagitis increases grocery shopping cost and complexity","volume":"31","author":"Asher Wolf","year":"2016","journal-title":"Dysphagia"},{"key":"10.1016\/j.gastha.2024.08.009_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2015.07.041","article-title":"Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis","volume":"14","author":"Lucendo","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib75","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1572-0241.2007.01379.x","article-title":"Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children","volume":"102","author":"Aceves","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib76","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/apt.14123","article-title":"Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis","volume":"46","author":"Moawad","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2024.08.009_bib78","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","article-title":"Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"8","author":"Rothenberg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib79","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa2312282","article-title":"Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age","volume":"390","author":"Chehade","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gastha.2024.08.009_bib80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fcimb.2017.00444","article-title":"The influence of proton pump inhibitors on the fecal microbiome of infants with gastroesophageal reflux-a prospective longitudinal interventional study","volume":"7","author":"Castellani","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.gastha.2024.08.009_bib81","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.3748\/wjg.v26.i36.5395","article-title":"Treatment of eosinophilic esophagitis with swallowed topical corticosteroids","volume":"26","author":"Nennstiel","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib82","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib83","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1038\/ctg.2015.9","article-title":"Topical steroid therapy for the treatment of eosinophilic esophagitis (EoE): a systematic review and meta-analysis","volume":"6","author":"Chuang","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","article-title":"Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children","volume":"6","author":"Schaefer","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib85","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2024.08.009_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-016-0154-9","article-title":"Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis","volume":"12","author":"Ahmet","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2015.11.026","article-title":"Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis","volume":"170","author":"Golekoh","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib89","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0000000000000848","article-title":"Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis","volume":"61","author":"Harel","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib90","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.14309\/ajg.0000000000001170","article-title":"Variability in practices of compounding budesonide for eosinophilic esophagitis","volume":"116","author":"Joshi","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib91","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2016.11.032","article-title":"Cost utility analysis of topical steroids compared with dietary elimination for treatment of eosinophilic esophagitis","volume":"15","author":"Cotton","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1442-2050.2012.01409.x","article-title":"Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy","volume":"27","author":"Kavitt","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.gastha.2024.08.009_bib93","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ajg.2009.657","article-title":"Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2024.08.009_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.gie.2015.05.044","article-title":"Unsedated transnasal esophagoscopy for monitoring therapy in pediatric eosinophilic esophagitis","volume":"83","author":"Friedlander","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastha.2024.08.009_bib95","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MPG.0000000000001019","article-title":"High prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia","volume":"62","author":"Gutierrez-Junquera","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib96","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10620-011-1991-5","article-title":"Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis","volume":"57","author":"Dohil","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2024.08.009_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MPG.0b013e3182716b7a","article-title":"Effect of proton pump inhibitor on esophageal eosinophilia","volume":"56","author":"Schroeder","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib98","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MPG.0000000000001952","article-title":"Long-term treatment with proton pump inhibitors is effective in children with eosinophilic esophagitis","volume":"67","author":"Guti\u00e9rrez-Junquera","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib99","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jamapediatrics.2020.5710","article-title":"Association between proton pump inhibitor use and risk of asthma in children","volume":"175","author":"Wang","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib100","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.2513","article-title":"Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood","volume":"172","author":"Mitre","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib101","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/apa.15213","article-title":"The effects of proton pump inhibitors on the microbiome in young children","volume":"109","author":"Levy","year":"2020","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.gastha.2024.08.009_bib102","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MPG.0b013e31812e0149","article-title":"Proton pump inhibitor utilization patterns in infants","volume":"45","author":"Barron","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MPG.0b013e31823890b4","article-title":"Proton pump inhibitor use in infants: FDA reviewer experience","volume":"54","author":"Chen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gastha.2024.08.009_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-019-00775-y","article-title":"Dysbiosis of the gut and lung microbiome has a role in asthma","volume":"42","author":"Hufnagl","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.gastha.2024.08.009_bib105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1096\/fj.04-3170fje","article-title":"Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients","volume":"19","author":"Untersmayr","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.gastha.2024.08.009_bib107","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cgh.2022.02.013","article-title":"Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib108","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/apt.14573","article-title":"Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis","volume":"47","author":"Philpott","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2024.08.009_bib109","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gastha.2024.08.009_bib110","first-page":"327","article-title":"Topical steroid therapy for eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2024.08.009_bib111","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.1323896111","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gastha.2024.08.009_bib112","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.1324022111","article-title":"Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gastha.2024.08.009_bib113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.gastha.2024.08.009_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.gastha.2024.08.009_bib115","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Ralpha antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc'h","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.gastha.2024.08.009_bib116","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gastha.2024.08.009_bib117","first-page":"143","article-title":"Administration of proton pump inhibitors in patients requiring enteral nutrition","volume":"34","author":"Wensel","year":"2009","journal-title":"P\u00a0T"},{"key":"10.1016\/j.gastha.2024.08.009_bib118","first-page":"398","article-title":"Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study","volume":"73","author":"Bredenoord","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2024.08.009_bib119","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:37:43Z","timestamp":1733013463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572324001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2772572324001249"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2024.08.009","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Burden and Spectrum of Symptoms That Impact Quality of Life in Pediatric Patients With Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}